As of 4:00pm ET
| +0.07 / +0.50%|
The 5 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 15.00. The median estimate represents a +13.48% increase from the last price of 14.10.
The current consensus among 5 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.